Transgene Biotek Ltd — Important, 13-04-2026: Company Update

Transgene Biotek has informed the exchange that a statement regarding the use of funds from public, rights, or preferential share issues is not required for the quarter ending March 31. This is because the company did not raise capital through any such issues during that period. Therefore, the associated compliance rule does not apply. The company also mentioned that it was unable to submit this as a 'NIL' entry via the standard electronic filing system.